StockMarketWire.com - RNA therapeutics developer Silence Therapeutics said chief financial officer Rob Quinn would present at a key conference in Boston.

Quinn would present at the at the Cowen Annual Health Care Conference on 2 March.


At 9:19am: [LON:SLN] Silence Therapeutics PLC share price was -1p at 407p



Story provided by StockMarketWire.com